Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@genomenon.com
Drug Name | CD19-22.BB.z CAR T cells |
Trade Name | |
Synonyms | |
Drug Descriptions |
CD19-22.BB.z CAR T cells are T-lymphocytes engineered to express a chimeric antigen receptor (CAR) that targets CD19 and CD22, which potentially induce killing of tumor cells expressing CD19 and/or CD22 and decrease tumor growth (PMID: 34312556, PMID: 29155426). |
DrugClasses | CD19 Immune Cell Therapy 65 CD22 Immune Cell Therapy 15 |
CAS Registry Number | NA |
NCIT ID | NA |
Therapy Name | Drugs | Efficacy Evidence | Clinical Trials |
---|---|---|---|
CD19-22.BB.z CAR T cells | CD19-22.BB.z CAR T cells | 0 | 5 |